Goodwin Biotech to work on opioid addiction vaccines project
Contract manufacturer Goodwin Biotechnology will work with Minneapolis Medical Research Foundation (MMRF) to develop vaccines to treat opioid addiction.
Archives for March 22, 2017
Amgen targets Roche in Europe with Herceptin biosimilar submission
Amgen has signalled its intention to take a share of the $6.9bn Herceptin market by filing its trastuzumab candidate in the EU.
US FDA fast-track designation for Humacyte's tissue-based hemodialysis product
Humacyte has received one of the first US FDA regenerative medicine designations for its investigational human acellular vessels (HAVs) candidate Humacyl.